February 01, 2024 BY Elizabeth Anderson

Novo Nordisk smiling all the way to the bank

During the first three quarters of 2023, these medicines helped the pharmaceutics research and development outfit top the GDP of its homeland, Denmark. This performance also catapulted Novo Nordisk to the top spot among European companies.  Wegovy, the weight loss drug, raked in sales of $4.5bn, increasing the overall sales of this segment by 154%.…

Read more